Medicine and Dentistry
Atherosclerosis
100%
Chronic Kidney Disease
53%
Cardiovascular Disease
45%
Heart Failure
38%
Glomerular Filtration Rate
33%
Diabetes
27%
Arteriosclerosis Obliterans
26%
Cardiovascular System
25%
Hazard Ratio
25%
Creatinine
23%
Albuminuria
18%
Apoplexy
18%
End Stage Renal Disease
16%
Cardiovascular Risk
15%
Ischemic Heart Disease
15%
Meta-Analysis
14%
Kidney Function
14%
Nephropathy
14%
Prevalence
13%
Cohort Analysis
12%
Isotopes of Calcium
12%
Coronary Artery
11%
Ankle Brachial Index
11%
Disease
11%
Blood Pressure
10%
Pulse Wave Velocity
9%
Systolic Blood Pressure
8%
Proportional Hazards Model
8%
Body Mass Index
8%
Infection
8%
Cardiovascular Mortality
8%
Arterial Stiffness
8%
Cohort Effect
7%
Cardiac Troponin
7%
Atrial Fibrillation
7%
All Cause Mortality
7%
Middle Age
7%
Renal Failure
6%
Biological Marker
6%
Amino Terminal Sequence
6%
Physical Activity
6%
Troponin T
6%
Heart Disease
6%
Cross Sectional Study
6%
Myocardial Infarction
6%
Drug Therapy
5%
Cystatin C
5%
Population
5%
Brain Natriuretic Peptide
5%
Acute Decompensated Heart Failure
5%
Keyphrases
Atherosclerotic Risk Factors
99%
Chronic Kidney Disease
41%
Peripheral Arterial Disease
31%
Cardiovascular Disease
29%
Heart Failure
26%
Confidence Interval
25%
Hazard Ratio
25%
Estimated Glomerular Filtration Rate
24%
Older Adults
22%
Cardiovascular Risk
21%
Diabetes
19%
Albuminuria
17%
Coronary Artery Disease
16%
Cardiovascular Mortality
16%
Albumin-to-creatinine Ratio
15%
Hospitalization
14%
All-cause Mortality
14%
Meta-analysis
12%
Kidney Function
12%
Risk Factors
12%
Hypertension
11%
ARIC Study
10%
Cardiovascular Outcomes
9%
Coronary Artery Calcium
9%
Incident Heart Failure
9%
Heart Failure with Preserved Ejection Fraction (HFpEF)
9%
Body Mass Index
9%
High Risk
8%
Japanese Workers
8%
Kidney Disease
8%
Ankle-brachial Index
8%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
8%
Blood Pressure
7%
Atrial Fibrillation
7%
High-sensitivity Cardiac Troponin
7%
Later Life
7%
Cardiovascular Risk Prediction
7%
Hospitalization Risk
7%
Community Surveillance
7%
Cystatin C (Cys C)
7%
United States
7%
End-stage Renal Disease
6%
Long-run Risk
6%
Hemoglobin A1c (HbA1c)
6%
Cardiovascular Disease Events
6%
Adjusted Hazard Ratio
6%
Disease Activity Score
6%
Systolic Blood Pressure
6%
Multi-Ethnic Study of Atherosclerosis
6%
Egfr
6%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
79%
Cardiovascular Disease
42%
Chronic Kidney Failure
34%
Heart Failure
27%
Creatinine
19%
Peripheral Occlusive Artery Disease
18%
Albuminuria
16%
Ischemic Heart Disease
14%
Cardiovascular Risk
14%
Prevalence
14%
All Cause Mortality
13%
End Stage Renal Disease
13%
Cohort Study
11%
Infection
9%
Cardiovascular Mortality
9%
Troponin T
8%
Atrial Fibrillation
7%
Disease
7%
Cystatin C
7%
Brain Natriuretic Peptide
7%
Biological Marker
6%
Heart Infarction
6%
Kidney Disease
6%
Natriuretic Factor
6%
Global Disease Burden
6%
Kidney Failure
5%
Adiponectin
5%
